Aller au contenu
Retour à la recherche

NCT06464237Recrutement en cours

Metacognitive Intervention in Youth With Oncological Disease - the Mio Study

Résumé

The aim of the Mio-Study is to address the current lack of effective treatment options to reduce cognitive and physical long-term problems in children and adolescents with cancer. Through the use of the Mio-App, cognitive and physical development will be strengthened and metacognitive thinking and awareness will increase. The Mio-App for children and adolescence with cancer will include a combination of cognitive and physical training tasks and prospective as well as retrospective metacognitive questions. In a randomized controlled trial, the App will be analysed for its efficacy on metacognitive thinking and executive functions. In particular, the investigators are interested in factors that affect the efficacy of the training program such as compliance, age, sex or the presence of fatigue. This study will give insight into the role of metacognition in cognitive and physical performance and will foster the development of children and adolescents with cancer in the long-term.

Critères d'inclusion

• Informed consent as documented by signature (see Informed Consent Form) of participants and / or parents / legal guardians • Age 8-16 years • A diagnosis of cancer either with or without CNS involvement. The participant will be included between 3 months before to 10 years after termination of treatment. • Treatment of cancer including either radiation, chemotherapy and/ or surgical tumor removal • German or French speaking

Critères d'exclusion

• Any other instable neurological condition (e.g. epilepsy) • A severe psychiatric disease (e.g., eating disorder) or severe learning disability • Known or suspected non-compliance • Drug or alcohol abuse • Inability to follow the procedures of the study, e.g. due to language problems • Enrolment of the investigator, his/her family members, employees and other dependent persons

Contacts

Les coordonnées de l'équipe de l'essai s'affichent sur demande.

Voir la fiche officielle de l'essai
Statut
Recrutement en cours
Phase
Sans phase (N/A)
Type d'étude
Interventionnelle
Pays
Suisse
Promoteur
Insel Gruppe AG, University Hospital Bern(Autre)
N° de protocole
BASEC2023-01196
Pathologies
Cancer
Interventions
Comportemental

Traitements évalués

  • Mio-App

Collaborateurs

University of Bern

Lieux · 1

  • Bern, SuisseInsespital, University Hospital BernRecrute dans ce centre

Au total, dans le monde, le seul centre listé au registre recrute.

Statut par centre selon le registre ClinicalTrials.gov (dernière mise à jour publiée : 26 novembre 2025).

Ce statut peut avoir changé et ne dit rien de votre éligibilité : avant toute démarche, vérifiez avec votre oncologue ou le centre.

Voir aussi

Autres versions

Ces résultats sont indicatifs et ne remplacent pas un avis médical — à discuter avec votre médecin.